Product Recalls in Connecticut

Product recalls affecting Connecticut — including food, drugs, consumer products, medical devices, and vehicles distributed to Connecticut. RecallDetector monitors distribution data from the FDA, USDA, CPSC, and NHTSA to show you which recalls are relevant to your area. 2,623 recalls have been distributed to Connecticut in the last 12 months.

51,038 total recalls
2,623 in last 12 months

Showing 83018320 of 13,380 recalls

DrugFebruary 8, 2017· X-Gen Pharmaceuticals Inc.

Recalled Item: Ibuprofen Lysine Injection Recalled by X-Gen Pharmaceuticals Inc. Due to...

The Issue: Presence of Particulate Matter

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class I — Serious Health HazardOngoing
Refund
DrugFebruary 7, 2017· Actavis Inc

Recalled Item: Levofloxacin Ophthalmic Solution Recalled by Actavis Inc Due to Failed...

The Issue: Failed Impurities/ Degradation Specifications: OOS for related compound...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class III — Low RiskOngoing
Refund
DrugFebruary 7, 2017· Teva Pharmaceuticals USA

Recalled Item: Buprenorphine and Naloxone Sublingual Tablets 8 mg/2 mg Recalled by Teva...

The Issue: Failed Impurities/Degradation Specifications

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugFebruary 3, 2017· SCA Pharmaceuticals

Recalled Item: Vancomycin HCl 1.5 g added to 0.9% Sodium Chloride 250 Recalled by SCA...

The Issue: Presence of particulate matter - this recall is due to a recent Hospira...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class I — Serious Health HazardOngoing
Refund
DrugFebruary 3, 2017· Amerisource Health Services

Recalled Item: GlipiZIDE Extended-release tablets Recalled by Amerisource Health Services...

The Issue: Failed dissolution specifications: Glipizide 2.5 mg ER Tablets exceeded...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugFebruary 3, 2017· SCA Pharmaceuticals

Recalled Item: Vancomycin HCl 1 g added to 0.9% Sodium Chloride 250 mL Bag For IV Use Only...

The Issue: Presence of particulate matter - this recall is due to a recent Hospira...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class I — Serious Health HazardOngoing
Refund
DrugFebruary 3, 2017· SCA Pharmaceuticals

Recalled Item: Vancomycin HCl 1.25 g added to 0.9% Sodium Chloride 250 mL Bag For IV Use...

The Issue: Presence of particulate matter - this recall is due to a recent Hospira...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class I — Serious Health HazardOngoing
Refund
DrugFebruary 3, 2017· SCA Pharmaceuticals

Recalled Item: Vancomycin HCl 1.5 gram added to 5% Dextrose 500 mL Recalled by SCA...

The Issue: Presence of particulate matter - this recall is due to a recent Hospira...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class I — Serious Health HazardOngoing
Refund
DrugFebruary 3, 2017· Apotex Inc.

Recalled Item: CycloSPORINE Capsules Recalled by Apotex Inc. Due to Failed...

The Issue: Failed Impurities/Degradations Specifications; out of specification results...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugFebruary 3, 2017· SCA Pharmaceuticals

Recalled Item: Vancomycin HCl 750 mg added to 250 mL 0.9% Sodium Chloride For IV Use Only...

The Issue: Presence of particulate matter - this recall is due to a recent Hospira...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class I — Serious Health HazardOngoing
Refund
DrugFebruary 3, 2017· SCA Pharmaceuticals

Recalled Item: Vancomycin HCl 1.25 g added to 5% Dextrose 250 mL Bag For IV Use Only...

The Issue: Presence of particulate matter - this recall is due to a recent Hospira...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class I — Serious Health HazardOngoing
Refund
DrugFebruary 3, 2017· SCA Pharmaceuticals

Recalled Item: Vancomycin HCl 750 mg added to 5% Dextrose 250 mL For IV Use Only Recalled...

The Issue: Presence of particulate matter - this recall is due to a recent Hospira...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class I — Serious Health HazardOngoing
Refund
DrugFebruary 2, 2017· Sage Products Inc

Recalled Item: Q Care Continue Care Kit for the non-ventilated patient Recalled by Sage...

The Issue: Labeling: Incorrect or Missing Lot and/or Exp Date: The expiration date of...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class III — Low RiskOngoing
Refund
DrugFebruary 2, 2017· Teva Pharmaceuticals USA

Recalled Item: Mimvey Lo (estradiol and norethindrone acetate tablets USP) Recalled by Teva...

The Issue: Failed Impurities/Degradation Specifications: out of specification test...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugFebruary 2, 2017· Sandoz Inc

Recalled Item: Transderm Scop (scopolamine) Transdermal System Recalled by Sandoz Inc Due...

The Issue: Labeling: Incorrect Instructions:outer carton contains the incorrect...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugJanuary 30, 2017· Mylan Pharmaceuticals Inc.

Recalled Item: Norethindrone Acetate and Ethinyl Estradiol Tablets Recalled by Mylan...

The Issue: Chemical Contamination: out of specification results for impurities were...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class III — Low RiskOngoing
Refund
DrugJanuary 30, 2017· Actavis Inc

Recalled Item: Glipizide extended-release tablets Recalled by Actavis Inc Due to Failed...

The Issue: Failed Dissolution Specifications. Above out of specification for...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugJanuary 30, 2017· Mylan Pharmaceuticals Inc.

Recalled Item: Tarina Fe 1/20 (Norethindrone Acetate and Ethinyl Estradiol Tablets Recalled...

The Issue: Chemical Contamination: out of specification results for impurities were...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class III — Low RiskOngoing
Refund
DrugJanuary 27, 2017· Pharmedium Services, LLC

Recalled Item: Buffered Lidocaine Recalled by Pharmedium Services, LLC Due to Labeling;...

The Issue: Labeling; Label Mixup; outer packaging is incorrectly labeled as Buffered...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class III — Low RiskOngoing
Refund
DrugJanuary 27, 2017· Mylan Institutional, Inc. (d.b.a. UDL Laboratories)

Recalled Item: Mirtazapine Tablets Recalled by Mylan Institutional, Inc. (d.b.a. UDL...

The Issue: Presence of Foreign Tablets/Capsules; possibility of Glipizide 10 mg tablets...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund